Intrinsic Value of S&P & Nasdaq Contact Us

Guardant Health, Inc. GH NASDAQ

NASDAQ Global Select • Healthcare • Medical - Diagnostics & Research • US • USD

SharesGrow Score
57/100
4/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$134.21
+55.3%

Stock Statistics — GH

Guardant Health, Inc. (GH) has a market capitalization of $11.33B and trades at $86.40. The 52-week range is 36.36-120.74.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -26, Earnings Per Share (EPS) of $-3.32, annual revenue of $982.02M.

The stock has a beta of 1.65, operates in the Healthcare sector.

Trading Data
Current Price$86.40
52-Week Range36.36-120.74
Volume1.81M
Avg Volume (30D)2.46M
Market Cap$11.33B
Beta (1Y)1.65
Company
IPO Date2018-10-04
Employees1,999
CEOHelmy Eltoukhy
CountryUS
ExchangeNASDAQ Global Select
CurrencyUSD
ISINUS40131M1099
CUSIP40131M109
Income (Latest Year)
Revenue$982.02M
Gross Profit$633.01M
EBITDA$-373.91M
Operating Income$-436.3M
Net Income$-416.28M
EPS$-3.32
EPS Diluted$-3.32
Shares Outstanding$125.37M
Balance Sheet (Latest Year)
Total Assets$2.01B
Current Assets$1.47B
Cash & ST Investments$1.2B
Total Liabilities$2.11B
Total Debt$1.68B
Net Debt$1.3B
Total Equity$-99.31M
Debt / Equity-16.94
Valuation Ratios
P/E Ratio-26
P/S Ratio11.54
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message